Fatimzahra Agouram

Fatimzahra Agouram

Auto-generated profile, based on publicly available information

Fatimzahra Agouram

Cadi Ayyad University, Morocco

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025
Verified
Book Chapter
Closed access
JLJawad Laadraoui
Jawad Laadraoui
HKHamid Kabdy
Hamid Kabdy
SOSara Oufquir
Sara Oufquir
MAMehdi Aitlarradia
Mehdi Aitlarradia
FAFatimzahra Agouram
Fatimzahra Agouram
BEBilal EL-MANSOURY
Bilal EL-MANSOURY
Secondary metabolites, bioactive compounds from plants, fungi, and microorganisms, show significant therapeutic potential for neurodegenerative and inflammatory diseases. This chapter highlights their mechanisms of action, including antioxidant activity, modulation of inflammatory pathways, and neuroprotection, supported by preclinical and clinical evidence. Key classes like alkaloids, flavonoids, terpenoids, and polyphenols are explored for their neuroprotective and anti-inflammatory properties, alongside phytochemical sources that emphasize their drug discovery potential. However, challenges such as limited bioavailability, stability, and toxicity hinder their clinical application. Addressing these issues through novel strategies could unlock their full potential in modern medicine. This chapter bridges natural product chemistry and clinical applications, providing insights to inspire further research into secondary metabolites as essential tools for combating complex diseases.

17 June 2025
Verified
Book Chapter
Closed access
JLJawad Laadraoui
Jawad Laadraoui
MAMehdi Aitlarradia
Mehdi Aitlarradia
KOKhadija Oubella
Khadija Oubella
FAFatimzahra Agouram
Fatimzahra Agouram
SOSara Oufquir
Sara Oufquir
BEBilal EL-MANSOURY
Bilal EL-MANSOURY
Behavioral addictions, including gambling, internet/gaming, and food addiction, profoundly affect individuals and society. This chapter examines their neurobiological underpinnings, highlighting dopaminergic pathways, neurotransmitter imbalances, and the neural circuits involved in reward processing and impulse control. It covers diagnostic methods, psychometric tools, and neuroimaging, and reviews treatments such as Cognitive Behavioral Therapy, mindfulness, and pharmacological interventions. Stigma, comorbidities, and relapse risks are addressed, alongside prevention strategies emphasizing education, community support, and regulation. Future directions focus on personalized medicine, genetic and epigenetic research, and digital tools for intervention. By integrating neuroscience, clinical practice, and public health, this chapter offers a comprehensive foundation for understanding and managing behavioral addictions.

7 November 2025
Verified
Book Chapter
Closed access
ZGZineb El Gabbas
Zineb El Gabbas
SOSara Oufquir
Sara Oufquir
FAFatimzahra Agouram
Fatimzahra Agouram
MLMehdi Ait Laaradia
Mehdi Ait Laaradia
JLJawad Laadraoui
Jawad Laadraoui
Multiple sclerosis (MS) is a chronic neurodegenerative disorder characterized by inflammation, demyelination, and progressive neurological impairment. This chapter explores the therapeutic potential of cannabinoid-based drugs in MS, focusing on their mechanisms of action, including anti-inflammatory, analgesic, and neuromodulatory effects. It provides an overview of current MS treatments informed by recent clinical studies, while emphasizing key challenges such as optimal dosing, toxicity, and limited bioavailability, which restrict effective symptom management. In parallel, the chapter examines advances in nanomedicine, particularly nano-cannabinoids, as innovative strategies to enhance drug delivery, improve safety profiles, and increase therapeutic efficacy. By integrating evidence from pharmacology, clinical trials, and nanotechnology, this chapter highlights both the opportunities and challenges of cannabinoids and nanocannabis approaches, offering a comprehensive perspective on their potential in MS management.

7 November 2025
Verified
Book Chapter
Closed access
HKHamid Kabdy
Hamid Kabdy
Abdelfatah AitbabaAbdelfatah Aitbaba
Abdelfatah Aitbaba
AHAzraida Hajar
Azraida Hajar
JYJaouhari Yasmina
Jaouhari Yasmina
OSOufquir Sara
Oufquir Sara
CAChait Abderrahman
Chait Abderrahman
Neurodegenerative diseases (NDDs) are progressive disorders involving the loss of neuronal structure and function, leading to cognitive, behavioral, and motor decline. With curative therapies lacking, interest has turned to naturally derived compounds with neuroprotective potential. Plant secondary metabolites show anti-inflammatory, antioxidant, and neuroprotective effects, making them promising candidates for NDD management. Cannabis sativa produces cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC), along with terpenes and flavonoids, which act on the endocannabinoid system to regulate neuroinflammation, oxidative stress, and neuronal plasticity, showing benefits in multiple sclerosis, epilepsy, anxiety, insomnia, Alzheimer's, and Parkinson's disease. Likewise, constituents of Nicotiana tabacum, including nicotine and related alkaloids, can influence neuroinflammatory pathways and provide neuroprotection at controlled doses. This chapter examines their therapeutic potential, mechanisms, evidence, and translational challenges.